Showing results (51-60 of 242) with videos related to

Sort By:
Pageof 25
BMC Cardiovascular Disorders|February 6, 2019
Serum IL8 is not associated with cardiovascular events but with all-cause mortalityIlais Moreno Velásquez, Ashwini Gajulapuri, Karin Leander, et al.
Atherosclerosis|April 25, 2015
Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarctionIlais Moreno Velásquez, Zahra Golabkesh, Henrik Källberg, et al.
Endocrinology, Diabetes & Metabolism|October 29, 2022
Type 1 diabetes recurrence after SARS-CoV-2 infection in a subject with pancreas transplantationValentina Popolla, Alessandro Rizzi, Linda Tartaglione, et al.
Thrombosis Journal|February 2, 2024
Causes of death after first time venous thromboembolismFrida Lonnberg, Andreas Roos, Maria Farm, et al.
BMC Public Health|January 11, 2014
Financial stress in late adulthood and diverse risks of incident cardiovascular disease and all-cause mortality in women and menAxel C Carlsson, Bengt Starrin, Bruna Gigante, et al.
Plos One|May 16, 2015
Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort studyPetter K Nyström, Axel C Carlsson, Karin Leander, et al.
International Journal of Cardiology|January 28, 2014
Association of interleukin 8 with myocardial infarction: results from the Stockholm Heart Epidemiology ProgramIlais Moreno Velásquez, Paolo Frumento, Katarina Johansson, et al.
Heart (British Cardiac Society)|July 5, 2012
Elevated ApoB serum levels strongly predict early cardiovascular eventsBruna Gigante, Karin Leander, Max Vikstrom, et al.
Pageof 25